1h Free Analyst Time
The infectious disease market is forecasted to grow by USD 160.8 billion during 2024-2029, accelerating at a CAGR of 14.7% during the forecast period. The report on the infectious disease market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of infectious diseases, growing awareness of infectious diseases, and strong drug pipeline.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The infectious disease market is segmented as below:
By Product
- Drugs
- Vaccines
By End-user
- Hospital
- Multispecialty clinic
- Others
By Type
- Bacterial infections
- Viral infections
- Fungal infections
- Parasitic infections
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the infectious disease market covers the following areas:
- Infectious Disease Market sizing
- Infectious Disease Market forecast
- Infectious Disease Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Product
9 Market Segmentation by End-user
10 Market Segmentation by Type
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity/Restraints
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global infectious disease market: Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., BioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Grifols SA, Hologic Inc., Meridian Bioscience Inc., Meril Life Sciences Pvt. Ltd., OraSure Technologies Inc., Perkin Elmer Inc., QIAGEN N.V., QuidelOrtho Corp., Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Trinity Biotech Plc.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is development of novel drugs."
According to the report, one of the major drivers for this market is the increasing prevalence of infectious diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Pfizer Inc.
- Gilead Sciences Inc.
- GlaxoSmithKline plc (GSK)
- Merck & Co. Inc.
- Johnson & Johnson
- AbbVie Inc.
- Sanofi S.A.
- AstraZeneca plc
- BioNTech SE
- Novartis International AG
- Hoffmann-La Roche AG
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Takeda Pharmaceutical Co. Ltd
- Boehringer Ingelheim GmbH
- Mylan N.V.
- CSL Limited
- Amgen Inc.
- Bayer AG
- Moderna Inc.
